The gastrointestinal side effects commonly reported with oral berberine (including diarrhoea, constipation, and abdominal discomfort) are often cited as reasons to seek alternative delivery methods, but switching to an unproven transdermal product is not a scientifically justified solution
doi: 10.2174/138161212799436593
FDA Safety Note: The FDA has raised concerns regarding some unapproved compounded GLP-1 products, including dosing errors and the use of semaglutide salt forms (such as semaglutide sodium or acetate), which differ from the active ingredient used in FDA-approved medications
Therefore, its crucial for healthcare providers and patients to carefully evaluate the risks and benefits of using Ozempic during pregnancy
Whilst injection site locationabdomen, thigh, or upper armdoes not significantly influence systemic side effects, proper injection technique and consistent site rotation are essential for reducing local reactions and optimising treatment tolerability
